Anti-NiV Drug Discovery Products

Nipah virus (NiV) is a member of the Henipavirus genus within the Paramyxoviridae family. The virus was first identified in 1998 in Malaysia, where it caused an outbreak of respiratory disease in humans and pigs. Since then, NiV infections have been reported in various countries in the world. NiV is primarily transmitted through respiratory secretions, such as coughing or sneezing. The NiV primarily targets the respiratory tract and nervous system of humans and animals, The infections cause symptoms such as fever, headache, and encephalitis. In severe cases, NiV infection can lead to death.

NiV is an enveloped virus with 150-200 nm in diameter. The NiV genome is a single-stranded RNA that encodes structural proteins, including the fusion protein (F), the attachment protein (G), and the matrix protein (M). These proteins are essential for the viral entry and replicate. At our lab, we provide anti-NiV antibodies that target various NIV antigens.